Taken together, alteration in AMPK, SIRT1, and mTOR activity occur in energy surplus states such as obesity and type 2 diabetes to compensate for mitochondrial dysfunction and metabolic disorders. This evidence concerns the gene SIRT1 and obesity due to melanocortin 4 receptor deficiency.